Comparison of the incidence and pattern of interstitial lung disease during erlotinib and gefitinib treatment in japanese patients with non-small cell lung cancer: The okayama lung cancer study group experience

Katsuyuki Hotta, Katsuyuki Kiura, Nagio Takigawa, Hiroshige Yoshioka, Shingo Harita, Shoichi Kuyama, Toshiro Yonei, Keiichi Fujiwara, Tadashi Maeda, Keisuke Aoe, Hiroshi Ueoka, Haruhito Kamei, Shigeki Umemura, Tomonori Moritaka, Yoshihiko Segawa, Haruyuki Kawai, Akihiro Bessho, Katsuya Kato, Masahiro Tabata, Mitsune Tanimoto

Research output: Contribution to journalArticlepeer-review

63 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Comparison of the incidence and pattern of interstitial lung disease during erlotinib and gefitinib treatment in japanese patients with non-small cell lung cancer: The okayama lung cancer study group experience'. Together they form a unique fingerprint.

Medicine & Life Sciences